219 related articles for article (PubMed ID: 11878888)
41. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
42. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.
Scherr M; Battmer K; Eder M; Schüle S; Hohenberg H; Ganser A; Grez M; Blömer U
Gene Ther; 2002 Dec; 9(24):1708-14. PubMed ID: 12457285
[TBL] [Abstract][Full Text] [Related]
43. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro.
Simmons A; Whitehead RP; Kolokoltsov AA; Davey RA
Virol J; 2006 Feb; 3():8. PubMed ID: 16507098
[TBL] [Abstract][Full Text] [Related]
44. Differential characteristics of HIV-based versus SIV-based lentiviral vector systems: Gene delivery to neurons and axonal transport of expressed gene.
Kitagawa R; Miyachi S; Hanawa H; Takada M; Shimada T
Neurosci Res; 2007 Apr; 57(4):550-8. PubMed ID: 17275114
[TBL] [Abstract][Full Text] [Related]
45. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
46. Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation.
Grunwald T; Pedersen FS; Wagner R; Uberla K
J Gene Med; 2004 Feb; 6(2):147-54. PubMed ID: 14978768
[TBL] [Abstract][Full Text] [Related]
47. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Kuate S; Wagner R; Uberla K
J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977
[TBL] [Abstract][Full Text] [Related]
48. Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection.
Okuma K; Boritz E; Walker J; Sarkar A; Alexander L; Rose JK
Virology; 2006 Mar; 346(1):86-97. PubMed ID: 16325218
[TBL] [Abstract][Full Text] [Related]
49. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.
Zufferey R; Nagy D; Mandel RJ; Naldini L; Trono D
Nat Biotechnol; 1997 Sep; 15(9):871-5. PubMed ID: 9306402
[TBL] [Abstract][Full Text] [Related]
50. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum.
DePolo NJ; Reed JD; Sheridan PL; Townsend K; Sauter SL; Jolly DJ; Dubensky TW
Mol Ther; 2000 Sep; 2(3):218-22. PubMed ID: 10985952
[TBL] [Abstract][Full Text] [Related]
51. Synergistic neuroprotective effect via simian lentiviral vector-mediated simultaneous gene transfer of human pigment epithelium-derived factor and human fibroblast growth factor-2 in rodent models of retinitis pigmentosa.
Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Kohno R; Murakami Y; Inoue M; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K; Ishibashi T
J Gene Med; 2008 Dec; 10(12):1273-81. PubMed ID: 18837062
[TBL] [Abstract][Full Text] [Related]
52. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
Chen P; Hübner W; Riviere K; Liu YX; Chen BK
Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
[TBL] [Abstract][Full Text] [Related]
53. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
[TBL] [Abstract][Full Text] [Related]
54. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
Klages N; Zufferey R; Trono D
Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
[TBL] [Abstract][Full Text] [Related]
55. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.
Schnell T; Foley P; Wirth M; Münch J; Uberla K
Hum Gene Ther; 2000 Feb; 11(3):439-47. PubMed ID: 10697118
[TBL] [Abstract][Full Text] [Related]
56. Quantification of HIV-based lentiviral vectors: influence of several cell type parameters on vector infectivity.
Gay V; Moreau K; Hong SS; Ronfort C
Arch Virol; 2012 Feb; 157(2):217-23. PubMed ID: 22042211
[TBL] [Abstract][Full Text] [Related]
57. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
[TBL] [Abstract][Full Text] [Related]
58. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus.
Kobayashi M; Iida A; Ueda Y; Hasegawa M
J Virol; 2003 Feb; 77(4):2607-14. PubMed ID: 12551999
[TBL] [Abstract][Full Text] [Related]
59. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
[TBL] [Abstract][Full Text] [Related]
60. Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors.
Lipinski DM; Barnard AR; Charbel Issa P; Singh MS; De Silva SR; Trabalza A; Eleftheriadou I; Ellison SM; Mazarakis ND; MacLaren RE
Hum Gene Ther; 2014 Jan; 25(1):50-62. PubMed ID: 24125177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
